Share: Facebook Twitter LinkedIn
Activity Provided By:

Physicians’ Education Resource®, LLC.

MGD-Associated Dry Eye Disease " How Emerging Options May Shift the Treatment Paradigm (COPE)

Access Activity

Overview / Abstract:

Target Audience
The target audience for this activity is optometrists and other health care professionals who are involved in the management of patients with MGD-associated DED.

Activity Overview
Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for treating MGD may ultimately provide new treatment alternatives.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from a live symposium held during the American Academy of Optometry Annual Meeting 2022 in October. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with MGD-associated DED, putting recent clinical trial data into clinical context. The program is designed for clinicians who did not attend the live meeting and to help reinforce learnings for those who did.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
Distinguish burden of disease associated with MGD-associated DED
Analyze key trial data surrounding therapies used for the treatment of MGD-associated DED
Recognize the mechanisms of action of emerging agents for the treatment of MGD-associated DED
Evaluate safety, efficacy, and key clinical trial data for emerging agents being studied for the potential treatment of MGD-associated DED

Expiration

Dec 21, 2023

Discipline(s)

Optometry / Ophthalmology CE

Format

Online

Credits / Hours

1.0 hours of Continuing Education credit by COPE

Accreditation

ACCME

Presenters / Authors / Faculty

1.0 hours of Continuing Education credit by COPE

Sponsors / Supporters / Grant Providers

Bausch + Lomb

Keywords / Search Terms

Relias LLC Relias LLC., Dry Eye Disease, FreeCME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map